Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fresh, Frozen or Lyophilized FMT for Recurrent C. Difficile
NCT02318992Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Aug 2013
- Primary completion
- Apr 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in Clostridium difficile infection (CDI), sponsored by UTHealth Houston. Started Aug 2013; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02318992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318992.